Exelixis Inc Sales Revenue, Goods, Net (Deprecated 2018-01-31)
Exelixis Inc (EXEL) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $145.84 million for the 3-month period ending 2018-06-29, per its 10-Q filed 2018-08-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsNet · last filed 2018-08-01
- Exelixis Inc sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2018-06-29 was $145.84M, a 65.72% increase year-over-year.
- Exelixis Inc sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2018-03-30 was $134.27M, a 94.94% increase year-over-year.
- Exelixis Inc sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $96.42M, a 125.58% increase year-over-year.
- Exelixis Inc sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $88.00M, a 178.34% increase year-over-year.
- Exelixis Inc sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2017 was $349.01M, a 157.81% increase from fiscal 2016.
- Exelixis Inc sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2016 was $135.38M.
- Exelixis Inc sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2016 was $135.38M, a 296.32% increase from fiscal 2016.
- Exelixis Inc sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2016 was $34.16M.
| Period end | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 24 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 27 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 30 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 33 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 36 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 39 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 42 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 45 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-06-29 | $145.84M 10-Q · filed 2018-08-01 | $280.11M 10-Q · filed 2018-08-01 | ||||||||||
| 2018-03-30 | $134.27M 10-Q · filed 2018-05-02 | |||||||||||
| 2017-12-29 | $349.01M 10-K · filed 2018-02-26 | |||||||||||
| 2017-09-30 | $96.42M 10-Q · filed 2017-11-01 | $184.42M derived: sum of 2 quarters · filed 2018-08-01 | $253.30M 10-Q · filed 2017-11-01 | $305.21M derived: sum of 4 quarters · filed 2018-08-01 | ||||||||
| 2017-06-30 | $88.00M 10-Q · filed 2018-08-01 | $156.88M 10-Q · filed 2017-08-02 | $208.80M derived: sum of 3 quarters · filed 2018-08-01 | $251.54M derived: sum of 4 quarters · filed 2018-08-01 | ||||||||
| 2017-03-31 | $68.88M 10-Q · filed 2017-05-01 | $120.79M derived: sum of 2 quarters · filed 2018-05-02 | $163.53M derived: sum of 3 quarters · filed 2018-05-02 | $195.15M derived: sum of 4 quarters · filed 2018-05-02 | ||||||||
| 2016-12-31 | $51.92M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $94.66M derived: sum of 2 quarters · filed 2017-11-01 | $126.28M derived: sum of 3 quarters · filed 2017-11-01 | $135.38M 10-K · filed 2017-02-27 | ||||||||
| 2016-12-30 | $135.38M 10-K · filed 2018-02-26 | |||||||||||
| 2016-09-30 | $42.74M 10-Q · filed 2017-11-01 | $74.36M derived: sum of 2 quarters · filed 2017-11-01 | $83.46M 10-Q · filed 2017-11-01 | $93.38M derived: sum of 4 quarters · filed 2017-11-01 | $157.70M 10-Q · filed 2016-11-03 | |||||||
| 2016-06-30 | $31.62M 10-Q · filed 2017-08-02 | $40.72M 10-Q · filed 2017-08-02 | $50.64M derived: sum of 3 quarters · filed 2017-08-02 | $57.49M derived: sum of 4 quarters · filed 2017-08-02 | $115.00M 10-Q · filed 2016-08-03 | |||||||
| 2016-03-31 | $9.10M 10-Q · filed 2017-05-01 | $19.02M derived: sum of 2 quarters · filed 2017-05-01 | $25.88M derived: sum of 3 quarters · filed 2017-05-01 | $33.87M derived: sum of 4 quarters · filed 2017-05-01 | $83.40M 10-Q · filed 2016-05-04 | |||||||
| 2016-01-01 | $34.16M 10-K · filed 2018-02-26 | |||||||||||
| 2015-12-31 | $9.92M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $16.78M derived: sum of 2 quarters · filed 2017-02-27 | $24.77M derived: sum of 3 quarters · filed 2017-02-27 | $34.16M 10-K · filed 2017-02-27 | $74.30M 10-K · filed 2016-02-29 | |||||||
| 2015-09-30 | $6.85M 10-Q · filed 2016-11-03 | $14.85M derived: sum of 2 quarters · filed 2016-11-03 | $24.23M 10-Q · filed 2016-11-03 | $31.59M derived: sum of 4 quarters · filed 2017-02-27 | $64.40M 10-Q · filed 2015-11-10 | |||||||
| 2015-06-30 | $7.99M 10-Q · filed 2016-08-03 | $17.38M 10-Q · filed 2016-08-03 | $24.73M derived: sum of 3 quarters · filed 2017-02-27 | $31.02M derived: sum of 4 quarters · filed 2017-02-27 | $57.50M 10-Q · filed 2015-08-11 | |||||||
| 2015-03-31 | $9.39M 10-Q · filed 2016-05-04 | $16.74M derived: sum of 2 quarters · filed 2017-02-27 | $23.03M derived: sum of 3 quarters · filed 2017-02-27 | $29.59M derived: sum of 4 quarters · filed 2017-02-27 | $49.50M 10-Q · filed 2015-04-30 | |||||||
| 2014-12-31 | $7.35M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $13.64M derived: sum of 2 quarters · filed 2017-02-27 | $20.21M derived: sum of 3 quarters · filed 2017-02-27 | $25.11M 10-K · filed 2017-02-27 | $40.10M 10-K · filed 2015-03-02 | |||||||
| 2014-09-30 | $6.29M 10-Q · filed 2015-11-10 | $12.85M derived: sum of 2 quarters · filed 2015-11-10 | $17.76M 10-Q · filed 2015-11-10 | $22.11M derived: sum of 4 quarters · filed 2016-02-29 | ||||||||
| 2014-06-30 | $6.56M 10-Q · filed 2015-08-11 | $11.47M 10-Q · filed 2015-08-11 | $15.81M derived: sum of 3 quarters · filed 2016-02-29 | $20.59M derived: sum of 4 quarters · filed 2016-02-29 | ||||||||
| 2014-03-31 | $4.91M 10-Q · filed 2015-04-30 | $9.25M derived: sum of 2 quarters · filed 2016-02-29 | $14.02M derived: sum of 3 quarters · filed 2016-02-29 | $18.07M derived: sum of 4 quarters · filed 2016-02-29 | ||||||||
| 2013-12-31 | $4.35M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $9.12M derived: sum of 2 quarters · filed 2016-02-29 | $13.16M derived: sum of 3 quarters · filed 2016-02-29 | $15.02M 10-K · filed 2016-02-29 | ||||||||
| 2013-09-30 | $4.77M 10-Q · filed 2014-11-04 | $8.81M derived: sum of 2 quarters · filed 2014-11-04 | $10.67M 10-Q · filed 2014-11-04 | $10.67M derived: sum of 4 quarters · filed 2015-03-02 | ||||||||
| 2013-06-30 | $4.04M 10-Q · filed 2014-07-31 | $5.90M 10-Q · filed 2014-07-31 | $5.90M derived: sum of 3 quarters · filed 2015-03-02 | $5.90M derived: sum of 4 quarters · filed 2015-03-02 | ||||||||
| 2013-03-31 | $1.86M 10-Q · filed 2014-05-01 | $1.86M derived: sum of 2 quarters · filed 2015-03-02 | $1.86M derived: sum of 3 quarters · filed 2015-03-02 | $1.86M derived: sum of 4 quarters · filed 2015-03-02 | ||||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $0.00 derived: sum of 2 quarters · filed 2015-03-02 | $0.00 derived: sum of 3 quarters · filed 2015-03-02 | $0.00 10-K · filed 2015-03-02 | ||||||||
| 2012-09-30 | $0.00 10-Q · filed 2013-10-30 | $0.00 derived: sum of 2 quarters · filed 2013-10-30 | $0.00 10-Q · filed 2013-10-30 | |||||||||
| 2012-06-30 | $0.00 10-Q · filed 2013-08-06 | $0.00 10-Q · filed 2013-08-06 | ||||||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-07 | |||||||||||
| 2011-12-31 | $0.00 10-K · filed 2014-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |